Drug Shortage Report for FYCOMPA
| Report ID | 216474 |
| Drug Identification Number | 02404540 |
| Brand name | FYCOMPA |
| Common or Proper name | perampanel |
| Company Name | EISAI LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PERAMPANEL |
| Strength(s) | 8.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 28 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-01-18 |
| Estimated end date | 2024-02-05 |
| Actual end date | 2024-01-31 |
| Shortage status | Resolved |
| Updated date | 2024-02-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6925 CENTURY AVE, SUITE 701 MISSISSAUGA, ONTARIO CANADA L5N 7K2 |
| Company contact information | Tammy Mitchell-Moore - Director, Regulatory Affairs 905-814-2312 / tammy_mitchellmoore@eisai.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-02-01 | French | Compare |
| v5 | 2024-02-01 | English | Compare |
| v4 | 2024-01-25 | French | Compare |
| v3 | 2024-01-25 | English | Compare |
| v2 | 2024-01-18 | French | Compare |
| v1 | 2024-01-18 | English | Compare |
Showing 1 to 6 of 6